This makes the UK the first country in which patients do not have to pay for the drug out of their own pocket
Why people switch The most common reasons include weight loss plateaus, inadequate response at maximum dose, side effect intolerance, cost or insurance changes, and desire for greater efficacy
Because cardiovascular disease remains the major cause of death worldwide, proving that GLP-1s prevent cardiac events and hospitalizations makes the drugs highly valuable to healthcare systems
Healthcare providers typically start with a lower dose of Wegovy (0.25 mg) and follow the standard dose-escalation schedule, with the dosage gradually increased every four weeks to minimize GI side effects
Titration refers to a gradual increase in dosage with a particular medication to allow the body time to get used to the medication until the target dose has been reached
A decision from the FDA is expected by spring 2026